Literature DB >> 12887904

A conformational switch controls the DNA cleavage activity of lambda integrase.

Hideki Aihara1, Hyock Joo Kwon, Simone E Nunes-Düby, Arthur Landy, Tom Ellenberger.   

Abstract

The bacteriophage lambda integrase protein (lambda Int) belongs to a family of tyrosine recombinases that catalyze DNA rearrangements. We have determined a crystal structure of lambda Int complexed with a cleaved DNA substrate through a covalent phosphotyrosine bond. In comparison to an earlier unliganded structure, we observe a drastic conformational change in DNA-bound lambda Int that brings Tyr342 into the active site for cleavage of the DNA in cis. A flexible linker connects the central and the catalytic domains, allowing the protein to encircle the DNA. Binding specificity is achieved through direct interactions with the DNA and indirect readout of the flexibility of the att site. The conformational switch that activates lambda Int for DNA cleavage exposes the C-terminal 8 residues for interactions with a neighboring Int molecule. The protein interactions mediated by lambda Int's C-terminal tail offer a mechanism for the allosteric control of cleavage activity in higher order lambda Int complexes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12887904     DOI: 10.1016/s1097-2765(03)00268-5

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  24 in total

1.  Two structural features of lambda integrase that are critical for DNA cleavage by multimers but not by monomers.

Authors:  Sang Yeol Lee; Hideki Aihara; Tom Ellenberger; Arthur Landy
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-19       Impact factor: 11.205

2.  A structural basis for allosteric control of DNA recombination by lambda integrase.

Authors:  Tapan Biswas; Hideki Aihara; Marta Radman-Livaja; David Filman; Arthur Landy; Tom Ellenberger
Journal:  Nature       Date:  2005-06-23       Impact factor: 49.962

3.  Trans cooperativity by a split DNA recombinase: the central and catalytic domains of bacteriophage lambda integrase cooperate in cleaving DNA substrates when the two domains are not covalently linked.

Authors:  Srisunder Subramaniam; Hari B Kamadurai; Mark P Foster
Journal:  J Mol Biol       Date:  2007-04-19       Impact factor: 5.469

4.  A biotin interference assay highlights two different asymmetric interaction profiles for lambda integrase arm-type binding sites in integrative versus excisive recombination.

Authors:  Dane Hazelbaker; Marco A Azaro; Arthur Landy
Journal:  J Biol Chem       Date:  2008-03-04       Impact factor: 5.157

5.  Mutational analysis and homology-based modeling of the IntDOT core-binding domain.

Authors:  Karolina Malanowska; Joel Cioni; Brian M Swalla; Abigail Salyers; Jeffrey F Gardner
Journal:  J Bacteriol       Date:  2009-01-23       Impact factor: 3.490

6.  A chimeric Cre recombinase with regulated directionality.

Authors:  David Warren; Gurunathan Laxmikanthan; Arthur Landy
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-14       Impact factor: 11.205

7.  The structure of an archaeal viral integrase reveals an evolutionarily conserved catalytic core yet supports a mechanism of DNA cleavage in trans.

Authors:  Brian J Eilers; Mark J Young; C Martin Lawrence
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

Review 8.  DNA arms do the legwork to ensure the directionality of lambda site-specific recombination.

Authors:  Marta Radman-Livaja; Tapan Biswas; Tom Ellenberger; Arthur Landy; Hideki Aihara
Journal:  Curr Opin Struct Biol       Date:  2005-12-20       Impact factor: 6.809

9.  IntDOT interactions with core sites during integrative recombination.

Authors:  Jennifer Laprise; Sumiko Yoneji; Jeffrey F Gardner
Journal:  J Bacteriol       Date:  2013-01-18       Impact factor: 3.490

10.  Requirements for catalysis in the Cre recombinase active site.

Authors:  Bryan Gibb; Kushol Gupta; Kaushik Ghosh; Robert Sharp; James Chen; Gregory D Van Duyne
Journal:  Nucleic Acids Res       Date:  2010-05-12       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.